Rhumbline Advisers Lowers Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Rhumbline Advisers trimmed its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 44.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,263 shares of the company's stock after selling 61,214 shares during the period. Rhumbline Advisers owned about 0.16% of Nu Skin Enterprises worth $561,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in NUS. Susquehanna International Group LLP boosted its position in Nu Skin Enterprises by 191.9% in the 4th quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock valued at $4,838,000 after buying an additional 461,608 shares during the period. Two Sigma Advisers LP boosted its position in Nu Skin Enterprises by 61.2% in the 4th quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares during the period. D. E. Shaw & Co. Inc. boosted its position in Nu Skin Enterprises by 15.5% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock valued at $15,512,000 after buying an additional 301,295 shares during the period. JPMorgan Chase & Co. boosted its position in Nu Skin Enterprises by 74.9% in the 4th quarter. JPMorgan Chase & Co. now owns 405,667 shares of the company's stock valued at $2,795,000 after buying an additional 173,710 shares during the period. Finally, Two Sigma Investments LP boosted its position in Nu Skin Enterprises by 24.2% in the 4th quarter. Two Sigma Investments LP now owns 700,500 shares of the company's stock valued at $4,826,000 after buying an additional 136,624 shares during the period. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Trading Up 0.6%

NYSE:NUS opened at $7.73 on Monday. Nu Skin Enterprises, Inc. has a one year low of $5.32 and a one year high of $12.57. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.29 and a current ratio of 2.02. The firm has a market cap of $381.69 million, a P/E ratio of -9.66 and a beta of 0.98. The firm has a 50-day simple moving average of $7.00 and a 200-day simple moving average of $7.09.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.15 by $0.08. The business had revenue of $364.49 million during the quarter, compared to analyst estimates of $352.06 million. Nu Skin Enterprises had a negative net margin of 2.30% and a positive return on equity of 6.99%. Equities analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 11th. Investors of record on Friday, May 30th were paid a dividend of $0.06 per share. The ex-dividend date was Friday, May 30th. This represents a $0.24 annualized dividend and a dividend yield of 3.11%. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -30.00%.

Insider Buying and Selling

In other news, insider Steven Keith Hatchett acquired 6,500 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average price of $7.54 per share, for a total transaction of $49,010.00. Following the purchase, the insider now directly owns 162,065 shares in the company, valued at $1,221,970.10. The trade was a 4.18% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Edwina D. Woodbury sold 4,532 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $8.44, for a total transaction of $38,250.08. Following the transaction, the director now owns 42,947 shares of the company's stock, valued at approximately $362,472.68. This trade represents a 9.55% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.